Bernasconi-Elias, P
Hu, T
Jenkins, D
Firestone, B
Gans, S
Kurth, E
Capodieci, P
Deplazes-Lauber, J
Petropoulos, K
Thiel, P
Ponsel, D
Hee Choi, S
LeMotte, P
London, A
Goetcshkes, M
Nolin, E
Jones, M D
Slocum, K
Kluk, M J
Weinstock, D M
Christodoulou, A
Weinberg, O
Jaehrling, J
Ettenberg, S A
Buckler, A
Blacklow, S C
Aster, J C
Fryer, C J
Article History
Received: 19 January 2016
Accepted: 7 March 2016
First Online: 9 May 2016
Competing interests
: P Bernasconi-Elias, T Hu, B Firestone, S Gans, E Kurth, P Capodieci, P LeMotte, A London, E Nolin, M Jones, K Slocum, are employees of Novartis Institutes for Biomedical Research. J Deplazes-Lauber, K Petropoulos, J Jaehrling are employees of MorphoSys AG. S Blacklow serves as a consultants for Novartis and receives research support through the Dana Farber–Novartis DDP. The remaining authors declare no conflict of interest.